Exact Mass: 289.0360046
Exact Mass Matches: 289.0360046
Found 205 metabolites which its exact mass value is equals to given mass value 289.0360046,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Succinyl-2-amino-6-ketopimelate
N-Succinyl-2-amino-6-ketopimelate is an intermediate in lysine biosynthesis. It is the fourth to last step in the synthesis of lysine and is converted. from tetrahydrodipicolinate via the enzyme tetrahydrodipicolinate N-succinyltransferase (EC 2.3.1.117). It is then converted to N-succinyl-L,L-2,6-diaminopimelate via the enzyme Succinyldiaminopimelate transferase (EC 2.6.1.17). N-Succinyl-2-amino-6-ketopimelate is an intermediate in lysine biosynthesis. It is the fourth to last step in the synthesis of lysine and is converted
Quinethazone
Quinethazone is only found in individuals that have used or taken this drug. It is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.As a diuretic, quinethazone inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like quinethazone also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of quinethazone is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
UNII-YS0KM9EX5L
C14H11NO4S (289.04087660000005)
N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)methanesulfonamide
C14H11NO4S (289.04087660000005)
2-[(6-Aminopurin-9-yl)methoxy]ethyl dihydrogen phosphate
Adrafinil
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
(4-Methoxyphenyl)-morpholin-4-yl-sulfanyl-sulfanylidene-$l^{5}-phosphane
Minoxidil sulphate
C9H15N5O4S (289.08447100000006)
Satranidazole
C8H11N5O5S (289.04808760000003)
p-coumaroyltriacetate
P-coumaroyltriacetate belongs to hydroxycinnamic acids and derivatives class of compounds. Those are compounds containing an cinnamic acid (or a derivative thereof) where the benzene ring is hydroxylated. P-coumaroyltriacetate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). P-coumaroyltriacetate can be found in a number of food items such as common thyme, cowpea, swiss chard, and groundcherry, which makes P-coumaroyltriacetate a potential biomarker for the consumption of these food products.
ADRAFINIL
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
5-oxo-1-[4-(trifluoromethoxy)phenyl]pyrrolidine-3-carboxylic acid
2-(4-chlorophenyl)-3-phenyl-1,3-thiazolidin-4-one
C15H12ClNOS (289.03280920000003)
3-Benzo[b]furan-2-yl-2-(tert-butylsulfonyl)acrylonitrile
2-(1,3-Dioxo-2,3-dihydro-1H-inden-2-yliden)-2-[(3-pyridylmethyl)amino]acetonitrile
N-[2,5-Dioxo-6-(hydroxymethyl)-7-oxabicyclo[4.1.0]hepta-3-ene-3-yl]salicylamide
2-[2,6-Bis(methylsulfinyl)-4-hydroxyphenyl]diazenecarboxamide
(-)-8S-3-bromo-5-hydroxy-4-methoxyphenylalanine|2-amino-3-(3-bromo-5-hydroxy-4-methoxyphenyl)propanoic acid
C10H12BrNO4 (288.99496519999997)
Isocarbophos
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
2-OXAZOLIDINONE, 3-(3-FLUOROPHENYL)-5-[[(METHYLSULFONYL)OXY]METHYL]-, (5R)-
2-AMINO-4-[2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLAMINO]-1,3,5-TRIAZINE 98
1-(3-FLUOROPHENYL)-1-TOSYL]METHYLISOCYANIDE
C15H12FNO2S (289.05727440000004)
TERT-BUTYL 2,4-DICHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE
5-chloro-7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidine
3,5-DINITROBENZOYL-N-(N-PROPYL)AMINE HYDROCHLORIDE
C10H12ClN3O5 (289.04654519999997)
Improsulfan
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
4-(6-CHLOROPYRIDINE-3-CARBONYL)BENZOIC ACID ETHYL ESTER
4-{[2-FLUORO-5-(METHYLSULFONYL)PHENYL]AMINO}-4-OXOBUTANOICACID
5-BROMO-N-(TERT-BUTYL)-2-CHLOROBENZAMIDE
C11H13BrClNO (288.98689780000007)
3-AMINO-3-(3-BROMO-4-HYDROXY-5-METHOXY-PHENYL)-PROPIONIC ACID
C10H12BrNO4 (288.99496519999997)
3-AMINO-3-(5-BROMO-3-METHOXY-2-HYDROXY-PHENYL)-PROPIONIC ACID
C10H12BrNO4 (288.99496519999997)
N-[(4-methoxyphenyl)methylidene]-4-methylbenzenesulfonamide
1-(2-FLUOROPHENYL)-1-TOSYL]METHYLISOCYANIDE
C15H12FNO2S (289.05727440000004)
N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide
A-TOSYL-(4-FLUOROBENZYL) ISOCYANIDE
C15H12FNO2S (289.05727440000004)
1-(3-CHLORO-BENZYL)-PIPERIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
C13H17Cl2NO2 (289.06362820000004)
2-(5-CHLORO-THIOPHEN-2-YL)-QUINOLINE-4-CARBOXYLIC ACID
4-(methylthio)-2-[(phenylsulfonyl)amino]butanoic acid
Methyl 3-(5-fluoro-2-(trifluoromethyl)-1H-indol-3-yl)propanoate
Benzamide,N-[2-(chloroacetyl)phenyl]-4-hydroxy- (9CI)
2-(4-bromo-2,5-dimethoxyphenyl)-2-methoxyethanamine
PYRIDINE-4-CARBOXYLIC ACID PENTAFLUOROPHENYL ESTER
5-AMINO-N-(2,3-DIHYDROXY-1-PROPYL)-ISOPHTHALAMIDE HYDROCHLORIDE
4-[(4-METHYLPHENYL)THIO]-3-NITROBENZOIC ACID
C14H11NO4S (289.04087660000005)
3-(4-FLUOROPHENYL)-5-(FURAN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE
C14H12FN3OS (289.06850740000004)
2-Ethylsulfonylimidazo[1,2-a]pyridine-3-sulfonamide
Tizanidine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002491 - Central Nervous System Agents > D000700 - Analgesics Tizanidine hydrochloride is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Target: α2-adrenergic receptor Tizanidine is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia. Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam. Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa. Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5\% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment.
(S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
1-Propanone,3-chloro-1-(10H-phenothiazin-10-yl)-
C15H12ClNOS (289.03280920000003)
5-NITRO-2-P-TOLYLSULFANYL-BENZOIC ACID
C14H11NO4S (289.04087660000005)
Satranidazole
C8H11N5O5S (289.04808760000003)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
methyl 2-amino-7-methoxy-4,5-dihydrobenzo[e][1]benzothiole-1-carboxylate
AMINO-(3-BROMO-4,5-DIMETHOXY-PHENYL)-ACETIC ACID
C10H12BrNO4 (288.99496519999997)
6-(CHLOROMETHYL)-2-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PYRIMIDIN-4-OL
(3-Chloro-4-fluorophenyl)[4-fluoro-4-(hydroxymethyl)-1-piperidinyl]methanone
N-(4-Chloro-3-cyano-6-ethoxy-7-quinolinyl)acetamide
1-Bromo-4,5-diethoxy-2-nitrobenzene
C10H12BrNO4 (288.99496519999997)
5-bromo-N-butyl-2-chlorobenzamide
C11H13BrClNO (288.98689780000007)
4-chloro-2-(4-fluorophenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
1-Propanone,2-chloro-1-(10H-phenothiazin-10-yl)-
C15H12ClNOS (289.03280920000003)
(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid
[3-[(2-chloro-4-methylphenyl)carbamoyl]phenyl]boronic acid
2-(3-Hydroxy-2-quinolyl)-1,3-indandione
C18H11NO3 (289.07388960000003)
4-(6-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
4-(4-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
2-(4-amino-3-methoxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
C10H9F6NO2 (289.05374459999996)
(4-((3-CHLORO-4-METHYLPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
(2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4,5-DIYL)DIMETHANOL
methyl 4-chloro-2-(trifluoromethyl)quinoline-6-carboxylate
3-[(2-HYDROXYETHYL)THIO]-6-NITRO-2,3-DIHYDRO-1H-1LAMBDA6-BENZO[B]THIOPHENE-1,1-DIONE
1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone
5-Bromo-1,2-dicarboxylic acid-1H-Pyrrole 1-(1,1-dimethylethyl) ester
C10H12BrNO4 (288.99496519999997)
2-(3,4-DIMETHOXY-PHENYL)-4-FLUORO-BENZOTHIAZOLE
C15H12FNO2S (289.05727440000004)
(2-Chloro-pyridin-3-yl)-(4-MethylaMino-piperidin-1-yl)-Methanone hydrochloride
C12H17Cl2N3O (289.07486120000004)
1-(4-broMo-2,3-difluorophenyl)-4-Methylpiperidine
C12H14BrF2N (289.02776080000007)
METHYL 4-CHLORO-6-TRIFLUOROMETHYL-QUINOLINE-2-CARBOXYLATE
(3-(4-CHLOROBENZO[D]THIAZOL-2-YL)PHENYL)BORONIC ACID
C13H9BClNO2S (289.01355540000003)
4-Desmethoxypropoxyl-4-chloro Rabeprazole Sulfide
C14H12ClN3S (289.04404220000004)
dicarbonyl(pentamethylcyclopentadienyl)molybdenum dimer
Methyl [1-(1,3-benzothiazol-2-yl)-5-hydroxy-1H-pyrazol-3-yl]acetate
(3-((3-CHLORO-2-METHYLPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
Methyl 1-(2-nitro-4-(trifluoromethyl)phenyl)cyclopropanecarboxylate
Benzofuro(3,2-d)pyrimidin-4(3H)-one, 8-chloro-2-((2S)-2-pyrrolidinyl)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
1-(5-Chloroindol-3-YL)-3-hydroxy-3-(2H-tetrazol-5-YL)-propenone
C12H8ClN5O2 (289.03664979999996)
(4-Methoxyphenyl)(morpholino)phosphinodithioic acid
3-(4-Methylphenyl)sulfonyl-1,3-benzoxazol-2-one
C14H11NO4S (289.04087660000005)
5-Hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one
3-[(1-Methyl-5-tetrazolyl)thio]-1-phenylpyrrolidine-2,5-dione
2-[(1-Oxo-3-phenylpropyl)amino]-3-thiophenecarboxylic acid methyl ester
6-Amino-2-methoxy-5-(phenylsulfonyl)nicotinonitrile
Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-(hydroxymethyl)phenyl)-
(2S)-5-[[amino-(sulfonatoamino)phosphoryl]amino]-2-azaniumylpentanoate
C5H14N4O6PS- (289.03716540000005)
2-Hydroxy-5-[2-(4-nitrophenyl)hydrazinyl]benzoic acid
5-Chloropyridin-3-yl benzo[b]thiophene-2-carboxylate
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
2-Chloro-5-[(2E)-2-(1-pyridin-2-ylethylidene)hydrazinyl]benzoic acid
2-[(2,5-Dimethoxyphenyl)sulfonyl-methylamino]acetic acid
N-(Carboxymethyl)-N,N,N-tris(carboxylatomethyl)ethylenediamine
2-[(4-Methyl-2-pyrimidinyl)thio]-1-(3-nitrophenyl)ethanone
N-{[2-(4-chlorophenyl)acetyl]oxy}pyridine-2-carboximidamide
2-[2-(3,5-Dimethyl-1-pyrazolyl)ethyl]-4-thiophen-2-ylthiazole
2-(Methanesulfonamido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
1-benzyl-3-[(E)-1-thiophen-2-ylethylideneamino]thiourea
Ethyl 5-amino-1-thieno[2,3-d]pyrimidin-4-ylpyrazole-4-carboxylate
6-Chloro-3-[2-(2-furanyl)-2-oxoethyl]-1,4-benzoxazin-2-one
(2R)-2-amino-3-[[5-(2-hydroperoxyethyl)-2,3-dihydroxyphenyl]thio]propanoic acid
2-amino-7-[4-hydroxy-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
3-(alpha-Hydroxy-4-nitrobenzyl)-2,5-dihydroxy-2,4,6-cycloheptatrien-1-one
Rel-(1R,5R,11R)-3-(4-nitrophenyl)-hydroxymethyl-6,7-dioxabicyclo(3.2.2)nona-3,8-dien-2-one
QUINETHAZONE
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators
(2S)-2-(3-carboxypropanamido)-6-Oxoheptanedioic acid
N-(6-Oxo-6H-benzo(c)chromen-2-yl)methanesulfonamide
C14H11NO4S (289.04087660000005)
fumisoquin C(1-)
A monocarboxylic acid anion that is the conjugate base of fumisoquin C, obtained from the deprotonation of the carboxy group. Major microspecies at pH 7.3.
2-(4-oxo-1h-quinazolin-2-yl)-1h-indole-3-carbaldehyde
3,10,19-triazapentacyclo[10.7.1.0²,⁷.0⁹,²⁰.0¹³,¹⁸]icosa-1(19),2(7),9(20),11,13(18),14,16-heptaene-6,8-dione
3,10,19-triazapentacyclo[10.7.1.0²,⁷.0⁹,²⁰.0¹³,¹⁸]icosa-1(20),2(7),9,11,13(18),14,16-heptaene-6,8-dione
(3z)-3-[(4-hydroxyphenyl)methylidene]-4h-cyclopenta[b]indole-1,2-dione
C18H11NO3 (289.07388960000003)
3-(methylsulfanyl)-n-(4-{[3-(methylsulfanyl)prop-2-enoyl]oxy}butyl)prop-2-enimidic acid
{[3-methoxy-2-(3-methyl-2,5-dioxopyrrolidin-1-yl)-3-oxopropyl]sulfanyl}acetic acid
16-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one
C18H11NO3 (289.07388960000003)